Integration of neoadjuvant chemotherapy and surgery in the treatment of patients with breast carcinoma

Breast Disease

Volumn 12, Issue , 2001, Pages 69-81

  Kuerer, H M ^a   Singletary, S E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; NAVELBINE; PACLITAXEL; RAZOXANE; TAMOXIFEN; TRASTUZUMAB;

ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; IMAGING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METASTASIS; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0034847069     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2001-12108     Document Type: Article

References (64)

1. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer
2. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
3. Multimodal treatment of locoregionally advanced breast cancer
4. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
5. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery
6. NSABP protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel
7. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
8. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
9. The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer
10. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
11. Carcinoma of the breast. II. Criteria of operability
12. Locally advanced noninflammatory breast cancer
13. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
14. Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination
15. Primary chemotherapy in surgically resectable breast cancer
16. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer
17. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute
18. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer
19. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice
20. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer
21. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging
22. Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging
23. Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
24. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status
25. Conservation surgery after primary chemotherapy in large carcinomas of the breast
26. Surgical considerations in preoperative chemotherapy of breast cancer
27. US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy
28. Preoperative or postoperative doxorubicin hydrochloride (Adriamycin): Which is better for wound healing?
29. Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity
30. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer
31. Neoadjuvant therapy
32. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
33. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: A flow cytometry study on fine needle aspirates
34. Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
35. Clinical decision-making in early breast cancer
36. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
37. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast
38. Multidisciplinary management of advanced primary and metastatic breast cancer
39. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma
40. New strategies in locally advanced breast cancer
41. Preoperative chemotherapy: A model for studying the biology and therapy of primary breast cancer
42. Breast conservation therapy for large primary and locally advanced breast cancers after induction chemotherapy
43. Breast conservation and tumor downstaging
44. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer
45. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy
46. Lymphatic mapping in the treatment of breast cancer
47. Sentinel lymph node biopsy is accurate following neoadjuvant chemotherapy for breast cancer
48. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
49. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer
50. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
51. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy
52. A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma
53. Multidisciplinary treatment approach to locally advanced non-inflammatory breast cancer using chemotherapy and radiotherapy with or without surgery
54. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver
55. Cryosurgery of breast cancer
56. Interstitial laser hyperthermia model development for minimally invasive therapy of breast carcinoma
57. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy
58. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm
59. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
60. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer
61. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: The University of Michigan experience
62. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer
63. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
64. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer